It is now known that the imbalance of tirzepatide for GIPR >> GLP1R, as well as the mid-position of the fatty diacid moiety, probably lend the molecule to superior effects on glycemia (and obesity, which is covered elsewhere) [64, 114]. Here, GIPR is linked to obesity due to melanocortin 4 receptor deficiency.